GVS received Israeli (AMAR)

GVS received Israeli (AMAR) MoH approval (Stage-I) to use GVS' HyperEye-CPD systems for:

(i) Non Incentive   tests (as good as PCR): testing personnel's saliva on-site and 

(ii) sensing indoor-air, to detect validity of bio aerosols (e.g. Sars-Cov-II viruses).